IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$511.30 USD
-0.97 (-0.19%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $511.21 -0.09 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
IDXX 511.30 -0.97(-0.19%)
Will IDXX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IDXX
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
Why Is Idexx (IDXX) Up 0.9% Since Last Earnings Report?
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About IDEXX (IDXX) Stock We Don't?
IDEXX (IDXX) Q2 Earnings Miss Estimates, 2024 View Down
Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for IDXX
Bullish Two Hundred Day Moving Average Cross - IDXX
IDEXX Laboratories Inc (IDXX) Trading Down 3.59% on Sep 11
IDEXX Laboratories Inc (IDXX)'s Winning Formula: Financial Metrics and Competitive Strengths
IDEXX Laboratories Inc (IDXX) Trading 3.25% Higher on Sep 10
Fidelity Growth Strategies Fund Q2 2024 Review